Clinical Trial Update: Clinical Progression and Costs in Benign Prostatic Hyperplasia Patients Treated With Early Versus Delayed Combination Therapy

View source ↗

Summary

This completed clinical trial compared early versus delayed combination therapy in Benign Prostatic Hyperplasia and examined clinical progression and costs.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Snippet

Sponsor: GlaxoSmithKline | Conditions: Benign Prostatic Hyperplasia | Status: COMPLETED